Publications by authors named "Yide Xin"
Article Synopsis
- Methamphetamine (MA) abuse leads to significant social issues, particularly sleep disturbances, which can increase the risk of relapse; thus, targeting gut microbiota might improve sleep quality and aid in addiction treatment.
- The study recruited 70 MA users and categorized them based on sleep quality using the Pittsburgh Sleep Quality Index (PSQI), revealing differences in gut microbiota between users with good and bad sleep.
- Key findings highlighted the association between the gut bacteria genus Sutterella and daytime dysfunction, suggesting it could serve as a biomarker for poor sleep quality in individuals addicted to MA.
Introduction: Methamphetamine (MA) abuse is a major public problem, and impulsivity is both a prominent risk factor and a consequence of addiction. Hence, clarifying the biological mechanism of impulsivity may facilitate the understanding of addiction to MA. The microbiota-gut-brain axis was suggested to underlie a biological mechanism of impulsivity induced by MA.
View Article and Find Full Text PDFBackground: Bipolar disorder (BD) is difficult to discriminate from major depressive disorder (MDD) before the appearance of mania or hypomania. This study was designed to identify whether patients with MDD and those who converted to BD are distinguishable using dynamic amplitude low-frequency fluctuations (dALFF) and describe the sex effects on the identification of the two disorders.
Methods: We compared the dALFF values of 35 BD patients who converted from MDD during the 2-year follow-up, 99 MDD patients, and 130 healthy controls (HCs) using two-way ANOVA.